T. Rowe Price Associates’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-92,000
Closed -$80K 3044
2024
Q3
$80K Sell
92,000
-144,100
-61% -$125K ﹤0.01% 2863
2024
Q2
$83K Sell
236,100
-42,604
-15% -$15K ﹤0.01% 2781
2024
Q1
$187K Buy
278,704
+10,373
+4% +$6.96K ﹤0.01% 2641
2023
Q4
$146K Buy
268,331
+3,218
+1% +$1.75K ﹤0.01% 2638
2023
Q3
$160K Buy
265,113
+35,290
+15% +$21.3K ﹤0.01% 2558
2023
Q2
$299K Buy
229,823
+4,633
+2% +$6.03K ﹤0.01% 2362
2023
Q1
$397K Buy
225,190
+65,039
+41% +$115K ﹤0.01% 2206
2022
Q4
$503K Buy
160,151
+5,015
+3% +$15.8K ﹤0.01% 2129
2022
Q3
$761K Buy
155,136
+8,826
+6% +$43.3K ﹤0.01% 1904
2022
Q2
$606K Buy
146,310
+5,700
+4% +$23.6K ﹤0.01% 2138
2022
Q1
$817K Buy
140,610
+2,444
+2% +$14.2K ﹤0.01% 2095
2021
Q4
$1.04M Buy
138,166
+49,453
+56% +$371K ﹤0.01% 2018
2021
Q3
$799K Buy
88,713
+6,881
+8% +$62K ﹤0.01% 2149
2021
Q2
$980K Sell
81,832
-7,549
-8% -$90.4K ﹤0.01% 2071
2021
Q1
$1.12M Sell
89,381
-51,389
-37% -$644K ﹤0.01% 1995
2020
Q4
$2.2M Sell
140,770
-16,633
-11% -$260K ﹤0.01% 1601
2020
Q3
$1.49M Hold
157,403
﹤0.01% 1647
2020
Q2
$1.41M Sell
157,403
-11,566
-7% -$104K ﹤0.01% 1654
2020
Q1
$1.08M Buy
168,969
+47,021
+39% +$299K ﹤0.01% 1672
2019
Q4
$1.02M Buy
121,948
+952
+0.8% +$7.97K ﹤0.01% 1872
2019
Q3
$1.1M Buy
120,996
+14,928
+14% +$135K ﹤0.01% 1778
2019
Q2
$1.14M Buy
106,068
+499
+0.5% +$5.37K ﹤0.01% 1788
2019
Q1
$1.01M Buy
105,569
+300
+0.3% +$2.86K ﹤0.01% 1837
2018
Q4
$1.21M Sell
105,269
-14,524
-12% -$167K ﹤0.01% 1726
2018
Q3
$2.03M Sell
119,793
-802
-0.7% -$13.6K ﹤0.01% 1617
2018
Q2
$1.71M Buy
120,595
+57,612
+91% +$818K ﹤0.01% 1633
2018
Q1
$1.2M Sell
62,983
-7,817
-11% -$149K ﹤0.01% 1713
2017
Q4
$1.16M Sell
70,800
-5,500
-7% -$90.2K ﹤0.01% 1728
2017
Q3
$1.15M Sell
76,300
-12,400
-14% -$186K ﹤0.01% 1744
2017
Q2
$781K Sell
88,700
-39,500
-31% -$348K ﹤0.01% 1875
2017
Q1
$667K Sell
128,200
-15,000
-10% -$78K ﹤0.01% 1952
2016
Q4
$437K Hold
143,200
﹤0.01% 2107
2016
Q3
$663K Buy
143,200
+44,700
+45% +$207K ﹤0.01% 1901
2016
Q2
$570K Buy
98,500
+17,900
+22% +$104K ﹤0.01% 1912
2016
Q1
$488K Buy
80,600
+17,600
+28% +$107K ﹤0.01% 1978
2015
Q4
$575K Sell
63,000
-6,400
-9% -$58.4K ﹤0.01% 1899
2015
Q3
$391K Buy
69,400
+7,300
+12% +$41.1K ﹤0.01% 2052
2015
Q2
$689K Buy
62,100
+12,000
+24% +$133K ﹤0.01% 1870
2015
Q1
$786K Buy
50,100
+3,100
+7% +$48.6K ﹤0.01% 1808
2014
Q4
$715K Hold
47,000
﹤0.01% 1813
2014
Q3
$507K Buy
47,000
+9,700
+26% +$105K ﹤0.01% 1930
2014
Q2
$570K Hold
37,300
﹤0.01% 1889
2014
Q1
$674K Buy
37,300
+4,600
+14% +$83.1K ﹤0.01% 1803
2013
Q4
$454K Sell
32,700
-7,100
-18% -$98.6K ﹤0.01% 1949
2013
Q3
$417K Hold
39,800
﹤0.01% 1963
2013
Q2
$311K Buy
+39,800
New +$311K ﹤0.01% 2053